News

The Shortcut AI agent for Excel could be the next boon — or threat — to white collar workers who spend all day in ...
Chart Industries is growing 30-40% annually and has a recession-resistant business model with long-term project visibility.
The European Commission (EC) has granted approval to Sanofi's Sarclisa in combination with a regimen of bortezomib, lenalidomide and dexamethasone (VRd) to treat multiple myeloma in adults. Sarclisa ...